Delayed Short Dental Implants With Immediate Loading (NCT07675772) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Delayed Short Dental Implants With Immediate Loading
72 participantsStarted 2026-07-01
Plain-language summary
\> Evaluation of the wound healing in immediate occlusal loading of endosseous delayed short dental implant with or without CGF or A-PRF.
\> Detection of the primary and secondary implant stability of immediate occlusal loading of endosseous delayed short dental implant with or without CGF or A-PRF.
\> Evaluation of the hard and soft tissue thickness after immediate occlusal loading of endosseous delayed short dental implant with or without CGF or A-PRF.
Who can participate
Age range
18 Years – 55 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
\-
• Patient aged 18 - 45 years old.
• Patients maintaining excellent oral hygiene standards.
• Systemically healthy patient.
• Single or multiple missing teeth in premolar and molar region.
• Patients should have adequate bone width volume (\>4 mm) and bone density with sufficient mesiodistal and interocclusal space. Bone height (≤10mm).
• The patient should physically and psychologically be able to tolerate short implant surgical procedure.
• Patient with a sufficient platelet count (\>200,000/mm3) for CGF and A-PRF preparation.
• Patients who provided informed consent.
Exclusion Criteria:
* \> Presence of active periodontal disease.
Patients with a significant medical history which contradicts placement of dental implants such as:
• Diabetes.
• Diseases affecting bone metabolism.
• Patients currently on antibiotics, steroids, hormonal therapy, or medications known to affect bone metabolism.
• Patients with a history of radiotherapy or chemotherapy, coagulation defects, or currently on anticoagulant treatment.
• Pregnant or lactating women.
• Patients with poor oral hygiene.
• Habits such as khat chewing, smoking and alcohol intake.
• Insufficient vertical interarch space.
• Temporomandibular joint disorder.
• Parafunctional habits.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Bleeding On Probing Index (BOP):
Timeframe: at baseline, after 6 months, and after 12 months.
2
Peri- implant mucosal tissue index (MTI):
Timeframe: at baseline, after 6 months, and after 12 months.
3
Jemt papilla index:
Timeframe: at baseline, after 6 months, and after 12 months.
4
Probing Pocket Depth (PPD)
Timeframe: at baseline, after 6 months, and after 12 months.
5
Modified plaque index (mPI):
Timeframe: at baseline, after 6 months, and after 12 months.
6
Mucosal recession (MR)
Timeframe: at baseline, after 6 months, and after 12 months.
7
Keratinized mucosa (KM)
Timeframe: at baseline, after 6 months, and after 12 months.